These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The Heparan Sulfate Proteoglycan Syndecan-1 Triggers Breast Cancer Cell-Induced Coagulability by Induced Expression of Tissue Factor. Hassan N; Bückreiß N; Efing J; Schulz-Fincke M; König P; Greve B; Bendas G; Götte M Cells; 2023 Mar; 12(6):. PubMed ID: 36980251 [TBL] [Abstract][Full Text] [Related]
24. Role of syndecan-1 in the interaction between dendritic cells and T cells. Kouwenberg M; Rops A; Bakker-van Bebber M; Diepeveen L; Götte M; Hilbrands L; van der Vlag J PLoS One; 2020; 15(7):e0230835. PubMed ID: 32701966 [TBL] [Abstract][Full Text] [Related]
25. Expression of syndecan-1 in papillary carcinoma of the thyroid with extracapsular invasion. Bologna-Molina R; González-González R; Mosqueda-Taylor A; Molina-Frechero N; Damián-Matsumura P; Dominguez-Malagón H Arch Med Res; 2010 Jan; 41(1):33-7. PubMed ID: 20430252 [TBL] [Abstract][Full Text] [Related]
26. Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration. Endo K; Takino T; Miyamori H; Kinsen H; Yoshizaki T; Furukawa M; Sato H J Biol Chem; 2003 Oct; 278(42):40764-70. PubMed ID: 12904296 [TBL] [Abstract][Full Text] [Related]
27. Reception of Slit requires only the chondroitin-sulphate-modified extracellular domain of Syndecan at the target cell surface. Chanana B; Steigemann P; Jäckle H; Vorbrüggen G Proc Natl Acad Sci U S A; 2009 Jul; 106(29):11984-8. PubMed ID: 19574454 [TBL] [Abstract][Full Text] [Related]
28. Role of Heparanase and Syndecan-1 in HSV-1 Release from Infected Cells. Sharma P; Kapoor D; Shukla D Viruses; 2022 Sep; 14(10):. PubMed ID: 36298711 [TBL] [Abstract][Full Text] [Related]
29. Heparan sulfate regulates targeting of syndecan-1 to a functional domain on the cell surface. Yang Y; Børset M; Langford JK; Sanderson RD J Biol Chem; 2003 Apr; 278(15):12888-93. PubMed ID: 12566461 [TBL] [Abstract][Full Text] [Related]
30. Syndecan-1 modulates the motility and resolution responses of macrophages. Angsana J; Chen J; Smith S; Xiao J; Wen J; Liu L; Haller CA; Chaikof EL Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):332-40. PubMed ID: 25550207 [TBL] [Abstract][Full Text] [Related]
31. Shed Syndecan-1 is involved in chemotherapy resistance via the EGFR pathway in colorectal cancer. Wang X; Zuo D; Chen Y; Li W; Liu R; He Y; Ren L; Zhou L; Deng T; Wang X; Ying G; Ba Y Br J Cancer; 2014 Nov; 111(10):1965-76. PubMed ID: 25321193 [TBL] [Abstract][Full Text] [Related]
32. Loss of syndecan-1 is associated with malignant conversion in skin carcinogenesis. Stepp MA; Pal-Ghosh S; Tadvalkar G; Rajjoub L; Jurjus RA; Gerdes M; Ryscavage A; Cataisson C; Shukla A; Yuspa SH Mol Carcinog; 2010 Apr; 49(4):363-73. PubMed ID: 20082322 [TBL] [Abstract][Full Text] [Related]
33. Syndecan-1 knock-down in decidualized human endometrial stromal cells leads to significant changes in cytokine and angiogenic factor expression patterns. Baston-Büst DM; Götte M; Janni W; Krüssel JS; Hess AP Reprod Biol Endocrinol; 2010 Nov; 8():133. PubMed ID: 21044331 [TBL] [Abstract][Full Text] [Related]
34. The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy. Yang Y; MacLeod V; Dai Y; Khotskaya-Sample Y; Shriver Z; Venkataraman G; Sasisekharan R; Naggi A; Torri G; Casu B; Vlodavsky I; Suva LJ; Epstein J; Yaccoby S; Shaughnessy JD; Barlogie B; Sanderson RD Blood; 2007 Sep; 110(6):2041-8. PubMed ID: 17536013 [TBL] [Abstract][Full Text] [Related]
36. Clinical implications in the shift of syndecan-1 expression from the cell membrane to the cytoplasm in bladder cancer. Miyake M; Lawton A; Dai Y; Chang M; Mengual L; Alcaraz A; Goodison S; Rosser CJ BMC Cancer; 2014 Feb; 14():86. PubMed ID: 24524203 [TBL] [Abstract][Full Text] [Related]
37. Syndecan-1-dependent suppression of PDK1/Akt/bad signaling by docosahexaenoic acid induces apoptosis in prostate cancer. Hu Y; Sun H; Owens RT; Gu Z; Wu J; Chen YQ; O'Flaherty JT; Edwards IJ Neoplasia; 2010 Oct; 12(10):826-36. PubMed ID: 20927321 [TBL] [Abstract][Full Text] [Related]
38. The role of the glypican and syndecan families of heparan sulfate proteoglycans in cardiovascular function and disease. Thota LNR; Chignalia AZ Am J Physiol Cell Physiol; 2022 Oct; 323(4):C1052-C1060. PubMed ID: 35993518 [TBL] [Abstract][Full Text] [Related]
39. The heparan sulfate proteoglycan syndecan is an in vivo ligand for the Drosophila LAR receptor tyrosine phosphatase. Fox AN; Zinn K Curr Biol; 2005 Oct; 15(19):1701-11. PubMed ID: 16213816 [TBL] [Abstract][Full Text] [Related]
40. Age-Related Variation of Syndecan-1 Levels in Saliva and Plasma of Healthy Individuals. Nam EJ; Ham JY; Song KE; Won DI; Lee NY Clin Lab; 2021 Sep; 67(9):. PubMed ID: 34542982 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]